- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06918028
An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings
To Construct an Interpretable Multi-modal Report Generating System For Fundus Diseases Based On Weakly Labelings
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
AI models for multimodal fundus imaging in the diagnosis of retinal diseases. AI models have demonstrated significant potential in assisting the diagnosis of various retinal diseases based on multimodal fundus imaging. In recent years, AI has rapidly advanced in the field of fundus disease imaging diagnostics. High-accuracy diagnostic models can be developed using large datasets of precisely annotated single-modal images. Fundus photography, which provides clinicians with an initial diagnostic impression, is widely accessible and can be obtained using simple imaging devices or even mobile devices. For instance, Cen et al. trained a deep learning system using 249,620 precisely annotated fundus photographs to diagnose 39 common retinal diseases, achieving diagnostic accuracies exceeding 90% for each condition.
However, fundus photography alone offers limited disease information, making it challenging to differentiate between diseases with similar manifestations. In addition, its diagnostic accuracy is heavily based on image quality and clinician expertise, which may lead to missed or misdiagnosed cases.
Optical coherence tomography (OCT) provides a three-dimensional analysis of the retinal layers, clearly revealing the severity and location of pathologies such as intraretinal and subretinal fluid. OCT has become a standard diagnostic and differential diagnostic tool for retinal diseases and is essential to guide the precise treatment and follow-up of conditions such as age-related macular degeneration and diabetic macular edema. AI-assisted OCT analysis can further enhance the follow-up and personalized treatment of retinal diseases. For example, Fauw et al. utilized 14,884 OCT images to diagnose more than 10 retinal diseases and map the location of the lesions.
The accurate diagnosis of retinal diseases also relies on dynamic and functional evidence. Fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) are indispensable for the location, characterization, and evaluation of the vascular function of the lesion. However, due to the complexity of interpreting angiographic images, the application of AI in FFA and ICGA analysis has only recently gained traction.
Moreover, most cases require multimodal imaging, including OCT, fundus photography, and angiography, to comprehensively locate and analyze the disease pathology. Additionally, integrating clinical data and patient medical history is crucial for an accurate diagnosis. Therefore, there is an urgent need to develop new AI models capable of integrating multi-modal data to assist clinicians in accurately diagnosing complex retinal diseases.
AI-Assisted Generation of Complex Medical Reports. The complexity and specialized nature of fundus imaging make image interpretation challenging, and the shortage of clinicians capable of generating precise reports further increases the workload of ophthalmologists and hinders early diagnosis and treatment of retinal diseases. AI-assisted report generation has the potential to address these challenges. Compared to simple image recognition and classification, developing AI models that generate textual interpretations from images is more complex, as it requires the machine to mimic a human-like understanding of image content. "Image-to-text" models incorporate various deep learning algorithms, including computer vision and natural language processing. Early models required millions of natural images to achieve satisfactory text generation, which is impractical for medical imaging due to limited datasets and extensive textual information. However, clinical reports generated by clinicians, based on comprehensive clinical data, detailed image analysis, and experience, can serve as high-quality training datasets for such models.
Currently, significant research efforts are focused on areas with large datasets and standardized report formats, such as chest X-rays, chest CT scans, and brain MRI. The widely used report generation databases include Open-IU, MIMIC-CXR, and PadChest, with MIMIC-CXR containing more than 270,000 chest radiograph reports. In ophthalmology, due to the complexity of fundus imaging interpretation and the relatively smaller size of the data set, research in this area is limited, particularly for highly specialized imaging modalities such as fundus angiography. Our team has successfully developed a fundus fluorescein angiography report generation dataset (FFA-IR) based on angiography images and the corresponding reports. Our report generation model can produce accurate bilingual reports (Chinese and English) for common and rare retinal diseases, with accuracy comparable to that of human retinal specialists, while significantly reducing report generation time.
- Weak Annotation: A Promising Approach for Training New Disease Diagnosis and Classification Models Traditional AI-assisted diagnostic models for medical imaging typically rely on large-scale, precisely annotated, high-quality images, as the accuracy of the training dataset is critical for model performance. When high annotation accuracy cannot be guaranteed, increasing the dataset size is often the only way to improve model performance. However, for complex datasets like fundus angiography images, the large number of diseases and variable manifestations exponentially increase the annotation difficulty. Additionally, clinical reports often contain uncertainties due to incomplete clinical data or varying levels of clinician expertise, leading to inaccuracies in diagnostic reports.
Weak annotation offers a promising solution to reduce annotation costs, improve annotation efficiency, and improve model generalizability. In natural image processing, weak annotation has been widely studied, with large-scale natural image datasets enabling the training of such models. In medical AI research, Guo et al. pioneered the use of weakly annotated datasets derived from brain CT reports, automatically extracting low-quality keyword information to accurately identify and locate four common brain pathologies. This approach demonstrated excellent generalizability across different centers and imaging devices. However, these systems were limited to broad categories of diseases and single-modal images, lacking the ability to diagnose specific diseases or generate detailed reports.
Based on preliminary findings and literature, we propose a hypothesis: Can weakly annotated imaging reports, combined with AI deep learning algorithms such as knowledge graphs and Transformer, be used to build an interpretable, multi-modal, multi-disease fundus report generation system? This project aims to refine existing AI models and develop a system that helps generate imaging diagnoses and reports for multiple retinal diseases. The results will not only reduce the workload of ophthalmologists, but also promote the widespread adoption of advanced fundus imaging techniques, ultimately improving the early diagnosis and treatment of blinding retinal diseases.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Wenjia Cai, Ph.D.
- Phone Number: +8615017593912
- Email: caiwenjia@gzzoc.com
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510080
- Zhongshan Ophthalmic Center
-
Contact:
- Ling Jin
- Phone Number: +862066604125
- Email: jinling@gzzoc.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Disease group: All multimodal fundus examination images containing fundus lesions, examined from January 2011 to December 2023, including fundus photography, as well as OCT, OCTA, FFA, ICGA, B-ultrasound and corresponding imaging reports. Images could be either clear or unclear, reports are either complete or incomplete.
- Normal group: All multimodal fundus examination images without fundus lesions, examined from January 2011 to December 2023, including fundus photography, as well as OCT, OCTA, FFA, ICGA, B-ultrasound and corresponding imaging reports. Images could be either clear or unclear, reports are either complete or incomplete.
Exclusion Criteria:
- Disease group: 1. The image has serious quality problems; 2. The diagnostic report lacks key information.
- Normal group: 1. The image has serious quality problems; 2. The diagnostic report lacks key information.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Disease group
With retinal or choroidal diseases
|
With fundus diseases
|
|
Normal group
Without retinal or choroidal diseases
|
Without fundus diseases
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fundus Fluorescein Angiography (FFA) images with corresponding report
Time Frame: Baseline
|
Fundus Fluorescein Angiography(FFA) images with corresponding report were collected.
FFA allows dynamic observation of changes in retinal blood vessels and lesions.
|
Baseline
|
|
Indocyanine Green Angiography (ICGA) images with report
Time Frame: Baseline
|
Indocyanine Green Angiography (ICGA) images with corresponding report were collected.
ICGA allows dynamic observation of changes in choroidal blood vessels and lesions.
|
Baseline
|
|
Fundus photography with corresponding report
Time Frame: Baseline
|
Fundus photography images with corresponding report were collected.
Fundus photography provides observation of morphological manifestations of the retina, the retinal blood vessels, the optic nerve, as well as lesions on the retina.
|
Baseline
|
|
Optical coherence tomography (OCT) images with corresponding report
Time Frame: Baseline
|
Optical coherence tomography (OCT) images with corresponding report were collected.
OCT images provides observation of changes in retinal thickness, morphology and manifestations of lesions in each retinal or choroidal layer, as well as lesions in the macular area and optic nerve
|
Baseline
|
|
Optical coherence tomography angiography (OCTA) images with corresponding report
Time Frame: Baseline
|
Optical coherence tomography angiography (OCTA) images with corresponding report were collected.
OCTA images provides observation of the density, morphology, and manifestations of retinal blood vessels, as well as the morphology and manifestations of retinal lesions
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bilingual Evaluation Understudy (BLEU) analysis
Time Frame: Through study completion, an average of 1 year
|
Bilingual Evaluation Understudy (BLEU) measures how closely a machine-generated text matches the reference texts to quantify the similarity between the generated text and reference texts.
|
Through study completion, an average of 1 year
|
|
Metric for Evaluation of Translation with Explicit Ordering (METEOR) analysis
Time Frame: Through study completion, an average of 1 year
|
Metric for Evaluation of Translation with Explicit Ordering (METEOR) considers precision, recall, alignment, and includes stemming and synonymy to quantify the similarity between the generated text and reference texts.
|
Through study completion, an average of 1 year
|
|
Recall-Oriented Understudy for Gisting Evaluation (ROUGE) analysis
Time Frame: Through study completion, an average of 1 year
|
Recall-Oriented Understudy for Gisting Evaluation (ROUGE) focuses on recall and measures the overlap of n-grams, contiguous sequences of n items (words, characters, or symbols) extracted from a given sample of text, between the generated and reference texts to quantify the similarity between the generated text and reference texts.
|
Through study completion, an average of 1 year
|
|
Pearson correlation analysis
Time Frame: Through study completion, an average of 1 year
|
To determine the degree of linear relationship between human evaluations and automated assessments.
|
Through study completion, an average of 1 year
|
|
Intersection-Over-Union (IOU) analysis
Time Frame: Through study completion, an average of 1 year
|
Also known as the Jaccard similarity coefficient, between the attention map regions of lesion images and the ground truth annotations to evaluate the accuracy of model interpretations.
|
Through study completion, an average of 1 year
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Endocrine System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Pathologic Processes
- Diabetes Mellitus
- Eye Diseases
- Diabetic Angiopathies
- Diabetes Complications
- Refractive Errors
- Uveal Diseases
- Retinal Degeneration
- Metaplasia
- Myopia
- Retinal Diseases
- Diabetic Retinopathy
- Macular Degeneration
- Choroidal Neovascularization
- Neovascularization, Pathologic
- Choroid Diseases
- Myopia, Degenerative
Other Study ID Numbers
- 2024KYPJ005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retinal Diseases
-
n-Lorem FoundationUniversity of California, San DiegoActive, not recruitingRetinal DystrophyUnited States
-
Shanghai General Hospital, Shanghai Jiao Tong University...RecruitingInherited Retinal DystrophiesChina
-
Samsung Medical CenterCompletedRetinal Detachment | Retinal Break
-
Gangnam Severance HospitalCompletedInherited Retinal Dystrophy Primarily Involving Sensory Retina | Inherited Retinal Dystrophy Primarily Involving Retinal Pigment EpitheliumKorea, Republic of
-
Fondation Ophtalmologique Adolphe de RothschildTerminatedHereditary Retinal DystrophiesFrance
-
Innostellar Biotherapeutics Co.,LtdActive, not recruitingInherited Retinal DystrophyChina
-
Duke UniversityRecruitingRetinal DystrophiesUnited States
-
Frontera TherapeuticsRecruitingBiallelic RPE65 Mutation-associated Retinal DystrophyChina
-
PYC TherapeuticsCompletedRetinal Dystrophy | PRPF31 Mutationassociated Retinal Dystrophy | RP11United States
-
Benha UniversityUnknownDystrophy, RetinalUnited Arab Emirates
Clinical Trials on With fundus diseases
-
Evolucare TechnologiesAssistance Publique - Hôpitaux de Paris; Slb Pharma; BPIfranceRecruitingGlaucoma | Age-Related Macular Degeneration | Diabetic Retinopathy | Diabetic Macular Edema | Age-related MaculopathyFrance
-
Versailles HospitalUnknown
-
Zagazig UniversityCompleted
-
Regione VenetoEuropean Commission; Local Health Authorities n. 4; Local Health Authorities... and other collaboratorsCompletedMultiple Chronic Diseases Among Diabetes Mellitus, Chronic Obstructive Pulmonary Diseases and Heart FailureItaly
-
University of EdinburghRecruitingCerebral Small Vessel Diseases | Vascular Dementia | Lacunar StrokeUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisRecruitingChronic Disease | Somatic DisordersFrance
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting
-
The Filatov Institute of Eye Diseases and Tissue...CheckEye LLC; OftacentroRecruitingDiabetic RetinopathyUkraine
-
Zhejiang UniversityNot yet recruitingDiabetic Retinopathy | Diabetic Macular EdemaChina
-
The Filatov Institute of Eye Diseases and Tissue...Komisarenko Institute of Endocrinology and Metobolism; CheckEye LLCRecruiting